Station F

← Back to your selection

Activity in this selectionOct 8, 2026 · Jan 1, 2026

Rounds participated in: 1
Confirmed lead rounds: 0
New companies: 1
Funding in participating rounds: $34.4M

By stage

Series A1

By primary sector

Enterprise software1

By country

France1

Rounds

1 in this selection

Sep 22

Biolevate

Biolevate automates evidence-based operational workflows for regulated life-sciences companies, helping enterprise teams organize and execute complex processes.

€30MSeries A

Participant